ANZ News
It is currently conducting clinical studies and expanding its teams in Australia and the US.
The AI model still has a modest prediction accuracy and is slated for a wider clinical trial soon.
It provides a range of information and resources to support people with down syndrome.
It claims to help people stop smoking in four weeks.
It is a home-based programme with 10 self-paced modules.
One of the projects will develop a digital navigator to support people with chronic conditions.
Also, scientists from the University of South Australia have developed tiny fibre sensors for remote patient monitoring.
The company also has pending approvals for the device in Australia and Thailand.
The online treatment has been licensed to Blue Note Therapeutics for the development of a counterpart version in North America.
It also plans to double its headcount over the next 12 months.